An overview of the
current data from PsoProtectMe

Current Data

We are committed to sharing data and are delighted to provide open access to summary information from PsoProtectMe. These data are preliminary and include a limited number of participants, so should not be used to inform clinical decision making.

PsoProtectMe surveys completed

Participants per country (≥10 participants):

Country Participants Country Participants
Argentina 60 Panama 11
Australia 27 Peru 14
Canada 41 Philippines 52
Chile 107 Poland 28
Denmark 50 Portugal 202
Hong Kong 18 Singapore 12
India 16 Spain 65
Ireland 33 Sweden 34
Japan 87 United Kingdom 1715
Netherlands 12 United States 171
Norway 14 Other (<10) 122

Summary data from PsoProtectMe’s first 2000 participants.

Average age: 47 years (range 3-91)

Average BMI: 26 kg/m2

Type of psoriasis: 1678 plaque psoriasis, 431 guttate psoriasis, 109 pustular psoriasis, 41 erythrodema


Smoking status:

Coexisting psoriatic arthritis:

Type of psoriasis treatment:

Psoriasis severity change during the pandemic:

Have you been diagnosed with or thought you had COVID-19?

Did you go to hospital A&E due to your COVID-19?

Did you stay in hospital due to your COVID-19?

Has your COVID-19 infection got better?